National Path Lab
Liver & Gastrointestinal Diseases

Cirrhosis

Cirrhosis is advanced liver fibrosis associated with progressive loss of liver function and complications such as portal hypertension and liver failure. Laboratory testing helps assess liver function, complications, underlying causes, and disease severity.

Liver enzymes may be normal or only mildly abnormal even in advanced liver disease — cirrhosis assessment may require blood tests, imaging, fibrosis assessment, and clinical evaluation together, not blood tests alone.

At National Path Lab (NPL), comprehensive testing is available to support the evaluation of suspected or known cirrhosis, including underlying cause investigation and complication screening.

Tests available
5
Tests available
Health package
1
Health package

Tests Available at NPL

LIVER FUNCTION TEST PANEL 1

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

COMPLETE BLOOD COUNT

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 500

ALPHAFETOPROTEIN; AFP, TUMOR MARKER

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1500

GFR (GLOMERULAR FILTRATION RATE), ESTIMATED

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 600

PROTHROMBIN TIME; PT INR

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 500

About Cirrhosis

Causes & Risk Factors

Cirrhosis represents the end stage of various chronic liver diseases, most commonly:

•  Chronic viral hepatitis (hepatitis B or C) — major causes of cirrhosis worldwide.

•  MASLD/fatty liver disease — an increasingly common cause of cirrhosis.

•  Alcohol-associated liver disease.

•  Autoimmune liver diseases, including autoimmune hepatitis and primary biliary cholangitis.

•  Other less common causes, including certain inherited metabolic liver conditions.

Symptoms & When to Test

Cirrhosis symptoms often develop gradually and may not appear until the disease is relatively advanced (compensated cirrhosis can be asymptomatic).

•  Fatigue

•  Abdominal swelling (ascites) in more advanced disease

•  Jaundice

•  Easy bruising or bleeding, related to impaired clotting factor production

•  Swelling in the legs

•  Confusion or altered mental status, in advanced disease (hepatic encephalopathy)

•  Often asymptomatic in earlier (compensated) stages

When Should You Consider Testing?

Evaluation is appropriate for known chronic liver disease requiring monitoring, symptoms suggestive of liver dysfunction, or when cirrhosis is suspected based on imaging or other clinical findings.

Why Tests Are Combined

Because liver enzymes alone can be normal or only mildly abnormal even in advanced cirrhosis, a broader panel — CBC (anemia, platelet count), bilirubin, albumin, and PT/INR (synthetic function) — together provides a more complete picture of how well the liver is actually functioning, beyond just detecting ongoing injury.

Creatinine/eGFR and sodium are included because advanced cirrhosis can be associated with kidney dysfunction and fluid/electrolyte abnormalities, which are important both for assessing severity and for guiding management of complications.

Viral hepatitis markers and, where appropriate, AFP for hepatocellular carcinoma surveillance address the underlying cause and a serious potential complication of cirrhosis respectively — identifying a treatable underlying cause and monitoring for cancer risk are both essential parts of comprehensive cirrhosis care.

Tests Available at NPL

Test Code

Test

Clinical Relevance

H0012

 

CBC

Evaluates anemia, leukocyte abnormalities, and platelet count.

B0046

LIVER FUNCTION TEST PANEL 1

Evaluates liver injury, jaundice and bilirubin metabolism. Assesses bilirubin metabolism and excretory function.

H0031

PT / INR

Evaluates coagulation and provides information about hepatic synthetic function.

B0035

Creatinine / eGFR

Assesses kidney function, important in advanced liver disease.

 

Viral Hepatitis Markers

Help identify hepatitis B or C as potential underlying causes.

I0005

AFP

May be used as part of hepatocellular carcinoma surveillance in appropriate patients, generally together with imaging.

Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.

Home Sample Collection

NPL offers convenient home sample collection for Cirrhosis blood tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Known chronic liver disease requiring monitoring

•  Unexplained abdominal swelling

•  Jaundice, easy bruising, or leg swelling

•  Confusion or altered mental status with known liver disease — seek prompt evaluation

•  Cirrhosis suspected based on imaging findings

Medical Disclaimer

Laboratory tests support the assessment of cirrhosis but should not be interpreted in isolation. Reference ranges and clinical significance may vary according to the laboratory, patient characteristics, and clinical context. Final interpretation should be made by a qualified healthcare professional.

Related Packages

CELIAC PANEL SCREENING

Test Includes
3 Tests

Rs. 5000

Frequently Asked Questions

No. Liver enzymes may be normal or only mildly abnormal even in advanced liver disease. Cirrhosis assessment may require blood tests, imaging, fibrosis assessment, and clinical evaluation together.
Most of these blood tests do not require fasting, though your doctor may request fasting if other metabolic tests are ordered simultaneously.
AFP may be used as part of hepatocellular carcinoma (liver cancer) surveillance in patients with cirrhosis, generally together with imaging, since cirrhosis significantly increases liver cancer risk.
No. While alcohol is one recognized cause, viral hepatitis, fatty liver disease, autoimmune conditions, and other causes can also lead to cirrhosis.
Established cirrhosis (fibrosis) is generally not reversible, though treating the underlying cause can often halt or slow further progression and help manage complications, as guided by your hepatologist.